Viral shedding in symptomatic patients with mild COVID-19: an experience with nebulized nasal treatment

J Biol Regul Homeost Agents. 2021 May-Jun;35(3):1155-1157. doi: 10.23812/21-137-L.

Authors

At Varricchio¹, I La Mantia², F P Brunese³, Al Varricchio⁴, G Ciprandi⁵

Affiliations

¹ UOSD Video-Endoscopia delle VAS, P.O. San Gennaro - ASL Napoli 1-centro, Naples, Italy.
² ENT Department, University of Catania, Catania, Italy.
³ Primary Care Paediatrics, ASL Caserta, Italy.
⁴ ENT Department, Ospedale Santobono, Naples, Italy.
⁵ Allergy Clinic, Casa di Cura Villa Montallegro, Genoa, Italy.

PMID: 34233453
DOI: 10.23812/21-137-L

No abstract available

Keywords: aerosolization; hyaluronic acid; hypertonic saline; mild COVID-19; topical antibiotics; viral shedding; xylitol.

Publication types

Letter

MeSH terms

Administration, Intranasal
COVID-19*
Humans
Nebulizers and Vaporizers
SARS-CoV-2
Saline Solution, Hypertonic
Virus Shedding

Substances

Saline Solution, Hypertonic